Clinical Trial Update: Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.

View source ↗

Summary

A Biosency-sponsored clinical trial is enrolling to monitor vital signs in patients with idiopathic pulmonary fibrosis before and after acute exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: Biosency | Conditions: Idiopathic Pulmonary Fibrosis | Status: RECRUITING